IRAK3 and neoplasm: In vitro, tumor cells trigger the deactivation of monocytes by IRAK-M-dependent upregulation marked by declined levels of pro-inflammatory cytokines, a characteristic of tolerance development against neoplasms that can justify the increased risk of infections in leukemia patients [353,354,355,356,357].